Potential Coverage of a Multivalent M Protein-Based Group A Streptococcal Vaccine

BACKGROUND: The greatest burden of Group A streptococcal (GAS) disease worldwide is due to acute rheumatic fever (ARF) and rheumatic heart disease (RHD). Safe, effective and affordable vaccines designed to prevent GAS infections that trigger ARF could reduce the overall global morbidity and mortalit...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dale, James B., Penfound, Thomas A., Tamboura, Boubou, Sow, Samba O., Nataro, James P., Tapia, Milagritos, Kotloff, Karen L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593940/
https://ncbi.nlm.nih.gov/pubmed/23375817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.01.019
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak